Chief Financial Officer
Graeme joined Valo as Chief Financial Officer in August 2020. He has a distinguished 30-year career as a financial executive in the biopharmaceutical sector with a broad range of experience successfully driving strategic financial operations.
Graeme was most recently CFO at Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company in Philadelphia. Prior to Tmunity, Graeme served as CFO of Intellia where he helped to scale the then newly public company from 80 to 250 employees, overseeing strategic operational financial functions, investor relations, IT and pre-commercial strategic planning to support their pipeline. He was also CFO at Anacor, which was acquired by Pfizer. In addition, Graeme spent over 20-years at Merck gaining extensive experience in finance and business leadership roles, not the least of which include CFO of U.S. Operations and Global Head of Investor Relations.
Graeme has been a dedicated coach and advisor over the last several years at both The National Interscholastic Cycling Association (NICA) and Teen Trail Corp, providing young people across the country with critical opportunities to build their physical and mental capabilities through cycling while becoming active members of their communities. He is also a Member of the Board of Advisors of the Pennsylvania Interscholastic Cycling League. Graeme holds an MBA from Durham University in England.